Literature DB >> 34249413

The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.

Chaoliang Liao1,2,3, Huiwen Liu1,2,3, Xiangjian Luo1,2,3,4,5.   

Abstract

Nasopharyngeal carcinoma (NPC) is a unique subtype of head and neck cancer that is endemic to Southern China and Southeast Asia. Due to the concealed location and intrinsic invasiveness of this disease, majority of NPC patients are diagnosed with advanced stages (III and IV) and poor prognosis. Chemoradiotherapy resistance is a major problem for NPC patients, leading to incomplete local elimination, recurrence and metastasis. Therefore, it is of great significance to seek novel biomarkers and effective therapeutic regimen for clinical management of this deadly cancer. Exosomes are tiny membrane vesicles with a lipid bilayer secreted by most cells in the body, which are widely distributed in various body fluids. They are functionally active in different physiopathological process by carrying and transmitting important signal molecules such as miRNA, mRNA, protein, lipid, etc. Exosomal miRNAs play an important role in tumorigenesis and development of NPC. They are extensively involved in NPC cell proliferation, migration, invasion, neovascularization, radiotherapy resistance and the regulation of tumor immune microenvironment through intercellular communication and control of gene expression. Moreover, exosomal miRNAs can be used as valuable biomarkers for early diagnosis and therapeutic targets of NPC. AJCR
Copyright © 2021.

Entities:  

Keywords:  Exosomes; miRNA; nasopharyngeal carcinoma

Year:  2021        PMID: 34249413      PMCID: PMC8263644     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  117 in total

Review 1.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.

Authors:  Alexander V Vlassov; Susan Magdaleno; Robert Setterquist; Rick Conrad
Journal:  Biochim Biophys Acta       Date:  2012-04-01

Review 2.  MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.

Authors:  Ming-Liang He; Millore X-M Luo; Marie C Lin; Hsiang-fu Kung
Journal:  Biochim Biophys Acta       Date:  2011-09-17

3.  Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.

Authors:  Angela B Y Hui; Jeff P Bruce; Nehad M Alajez; Wei Shi; Shijun Yue; Bayardo Perez-Ordonez; Wei Xu; Brian O'Sullivan; John Waldron; Bernard Cummings; Patrick Gullane; Lillian Siu; Fei-Fei Liu
Journal:  Clin Cancer Res       Date:  2011-10-26       Impact factor: 12.531

4.  RIP3 mediates TCN-induced necroptosis through activating mitochondrial metabolism and ROS production in chemotherapy-resistant cancers.

Authors:  Xu Zhao; Jing Quan; Yue Tan; Ying Liu; Chaoliang Liao; Zhenzhen Li; Weihua Liao; Jikai Liu; Ya Cao; Xiangjian Luo
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

5.  MicroRNA-30a promotes invasiveness and metastasis in vitro and in vivo through epithelial-mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients.

Authors:  Hai-Yun Wang; Yang-Yang Li; Sha Fu; Xiao-Pai Wang; Ma-Yan Huang; Xiao Zhang; Qiong Shao; Ling Deng; Mu-Sheng Zeng; Yi-Xin Zeng; Jian-Yong Shao
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-08

6.  microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network.

Authors:  Liming Zhang; Tan Deng; Xiayu Li; Huaying Liu; Houde Zhou; Jian Ma; Minghua Wu; Ming Zhou; Shourong Shen; Xiaoling Li; Zhaoxia Niu; Wenling Zhang; Lei Shi; Bo Xiang; Jianhong Lu; Li Wang; Dan Li; Hailin Tang; Guiyuan Li
Journal:  Carcinogenesis       Date:  2010-01-06       Impact factor: 4.944

7.  Profiling miRNAs in nasopharyngeal carcinoma FFPE tissue by microarray and Next Generation Sequencing.

Authors:  Jin Peng; Yanjun Feng; Gabriel Rinaldi; Paul Levine; Samantha Easley; Elizabeth Martinez; Salman Hashmi; Nader Sadeghi; Paul J Brindley; Jason P Mulvenna; Jeffrey M Bethony; Jordan L Plieskatt
Journal:  Genom Data       Date:  2014-08-27

8.  Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.

Authors:  Xiaolan Zhu; Huiling Shen; Xinming Yin; Meiling Yang; Hong Wei; Qi Chen; Fan Feng; Yueqin Liu; Wenlin Xu; Yuefeng Li
Journal:  J Exp Clin Cancer Res       Date:  2019-02-15

9.  Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma.

Authors:  Fang-Zhu Wan; Kai-Hua Chen; Yong-Chu Sun; Xi-Chan Chen; Ren-Ba Liang; Li Chen; Xiao-Dong Zhu
Journal:  J Transl Med       Date:  2020-01-08       Impact factor: 5.531

10.  Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis.

Authors:  J Lu; X Xu; X Liu; Y Peng; B Zhang; L Wang; H Luo; X Peng; G Li; W Tian; M He; X Li
Journal:  Br J Cancer       Date:  2013-12-10       Impact factor: 7.640

View more
  3 in total

1.  Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma.

Authors:  Jing Quan; Can Cheng; Yue Tan; Nian Jiang; Chaoliang Liao; Weihua Liao; Ya Cao; Xiangjian Luo
Journal:  Int J Biol Sci       Date:  2022-03-14       Impact factor: 6.580

2.  Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.

Authors:  Jiahui Jiang; Qiao Tang; Jiaoe Gong; WeiHong Jiang; Yiting Chen; Qi Zhou; Alaa Aldeen; Shuanglian Wang; Chengmin Li; Wuwu Lv; Tao Du; Xingwei Wang; Xueying Long; Xueping Feng
Journal:  Int J Biol Sci       Date:  2022-02-21       Impact factor: 6.580

Review 3.  Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.

Authors:  Hai-Long Li; Nian-Hua Deng; Xiu-Sheng He; Yue-Hua Li
Journal:  Biomark Res       Date:  2022-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.